Piasecki, Thomas M <br/><br/>
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.  [electronic resource] 

 -  Experimental and clinical psychopharmacology  Nov 2003 
 - 276-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1064-1297 
<br/><br/><label>Standard No.: </label>10.1037/1064-1297.11.4.276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Bupropion--therapeutic use<br/>Chi-Square Distribution<br/>Dopamine Uptake Inhibitors--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Nicotine--adverse effects<br/>Nicotinic Agonists--adverse effects<br/>Predictive Value of Tests<br/>Psychiatric Status Rating Scales<br/>Recurrence<br/>Severity of Illness Index<br/>Smoking<br/>Smoking Cessation--methods<br/>Substance Withdrawal Syndrome--drug therapy<br/>Time Factors<br/>Tobacco Use Disorder--drug therapy<br/>Treatment Outcome